Q3 2025 Recap: Ophthalmology News and Updates

The third quarter of 2025 saw a slew of critical trial results, from investigating treatment interval extension in diabetic macular edema (DME) to providing alternative treatment methods for difficult diseases like Stargardt Disease, and a handful of promising approvals from the US Food and Drug Administration (FDA).